We are live on ! Find out more
RSCM

Rail-Splitter Capital Management Portfolio holdings

AUM $89.4M
1-Year Est. Return 15.13%
This Fund
S&P 500
This Quarter Est. Return
+13.95%
1 Year Est. Return
+15.13%
3 Year Est. Return
+64.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$327M
AUM Growth
+$22.9M
Cap. Flow
-$8.69M
Cap. Flow %
-2.66%
Top 10 Hldgs %
39.03%
Holding
45
New
9
Increased
15
Reduced
10
Closed
11

Top Buys

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$11.7M
2
DLTR icon
Dollar Tree
DLTR
+$10.4M
3
SHW icon
Sherwin-Williams
SHW
+$9.04M
4
CBOE icon
Cboe Global Markets
CBOE
+$9.01M
5
ABBV icon
AbbVie
ABBV
+$8.87M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$10.8M
2
THC icon
Tenet Healthcare
THC
+$8.88M
3
MDT icon
Medtronic
MDT
+$8.66M
4
AKRX
Akorn Inc
AKRX
+$7.93M
5
ZU
ZULILY INC CLASS A COMMON STOCK
ZU
+$6.66M

Sector Composition

Rank Sector Weight
1 Technology 20.22%
2 Healthcare 16.39%
3 Consumer Discretionary 15.12%
4 Industrials 11.12%
5 Financials 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COR icon
26
Cencora
COR
$60.6B
$8.15M 2.49%
90,371
-26,565
-23% -$2.28M
PFPT
27
DELISTED
Proofpoint, Inc.
PFPT
$8.14M 2.49%
151,378
+4,815
+3% +$206K
CHKP icon
28
Check Point Software Technologies
CHKP
$13B
$8.12M 2.48%
+103,320
New +$7.68M
ULTA icon
29
Ulta Beauty
ULTA
$22B
$7.42M 2.27%
58,038
+9,610
+20% +$1.18M
BKNG icon
30
Booking.com
BKNG
$149B
$7.25M 2.22%
158,450
-41,350
-21% -$1.87M
BDBD
31
DELISTED
BOULDER BRANDS INC
BDBD
$6.08M 1.86%
+549,234
New +$5.79M
GILD icon
32
Gilead Sciences
GILD
$162B
$4.01M 1.23%
42,598
-38,405
-47% -$3.97M
EHTH icon
33
eHealth
EHTH
$42.2M
$2.58M 0.79%
+103,339
New +$2.51M
PLAY icon
34
Dave & Buster's
PLAY
$377M
$2.13M 0.65%
+77,909
New +$1.7M
BFH icon
35
Bread Financial
BFH
$4.37B
– –
-26,227
Closed -$5.2M
CIEN icon
36
Ciena
CIEN
$53.4B
– –
-330,644
Closed -$5.53M
HOG icon
37
Harley-Davidson
HOG
$2.58B
– –
-94,402
Closed -$5.49M
MDT icon
38
Medtronic
MDT
$109B
– –
-139,791
Closed -$8.66M
MRK icon
39
Merck
MRK
$322B
– –
-191,466
Closed -$10.8M
THC icon
40
Tenet Healthcare
THC
$20.5B
– –
-149,467
Closed -$8.88M
LL
41
DELISTED
LL Flooring Holdings, Inc.
LL
– –
-113,182
Closed -$6.49M
GRUB
42
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
– –
-92,887
Closed -$6.36M
AKRX
43
DELISTED
Akorn Inc
AKRX
– –
-218,608
Closed -$7.93M
SFLY
44
DELISTED
Shutterfly, Inc.
SFLY
– –
-101,810
Closed -$4.96M
ZU
45
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
– –
-175,747
Closed -$6.66M
1
2

Similar funds

KC
Kanha Capital New York $89.9M AUM
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QGI
Quadrangle GP Investors New York $93.6M AUM 10.64% 1-Year Est. Return
ZC
Zelman Capital Beachwood, Ohio $81.9M AUM 22.32% 1-Year Est. Return
TF
Trutina Financial Bellevue, Washington $76.7M AUM 19.34% 1-Year Est. Return
SAM
Sunnymeath Asset Management Red Bank, New Jersey $71.2M AUM 26.55% 1-Year Est. Return
NA
NS Advisors Westport, Connecticut $71M AUM 25.21% 1-Year Est. Return
NCIM
New Century Investment Management Southfield, Michigan $70.5M AUM 23.2% 1-Year Est. Return

Rail-Splitter Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Rail-Splitter Capital Management held 45 positions worth $327M, up 7.5% from $304M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Rail-Splitter Capital Management's Q4 2014 filing shows 9 new, 15 increased, 10 reduced and 11 closed positions. Its largest new stake was COVIDIEN PLC COM SHS NEW (IRELAND): 121,970 shares worth $12.5M. The largest sale was Merck, an estimated $10.8M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Rail-Splitter Capital Management's largest Q4 2014 buy was COVIDIEN PLC COM SHS NEW (IRELAND): 121,970 shares worth $12.5M.
  • Rail-Splitter Capital Management added most to Cognizant in Q4 2014, an estimated $3.02M increase.
  • Rail-Splitter Capital Management's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $3.97M.
  • Rail-Splitter Capital Management fully exited Merck in Q4 2014, selling an estimated $10.8M.
  • Rail-Splitter Capital Management's ten largest holdings make up 39% of its $327M portfolio in Q4 2014.
  • Rail-Splitter Capital Management opened 9 new positions and closed 11 in Q4 2014.
  • Rail-Splitter Capital Management's portfolio value rose 7.5% quarter-over-quarter to $327M.

Based on Rail-Splitter Capital Management's 13F filing for Q4 2014, filed 15 Jan 2015.